Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Intangibles (2016 - 2019)

Aptevo Therapeutics (APVO) has disclosed Intangibles for 4 consecutive years, with $4.4 million as the latest value for Q4 2019.

  • Quarterly Intangibles fell 15.81% to $4.4 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2019, down 15.81% year-over-year, with the annual reading at $4.4 million for FY2019, 15.81% down from the prior year.
  • Intangibles hit $4.4 million in Q4 2019 for Aptevo Therapeutics, down from $4.6 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $14.0 million in Q1 2017 to a low of $4.4 million in Q4 2019.
  • Historically, Intangibles has averaged $6.8 million across 4 years, with a median of $5.7 million in 2018.
  • Biggest five-year swings in Intangibles: fell 12.01% in 2017 and later plummeted 58.09% in 2018.
  • Year by year, Intangibles stood at $6.9 million in 2016, then dropped by 12.01% to $6.1 million in 2017, then dropped by 13.65% to $5.2 million in 2018, then dropped by 15.81% to $4.4 million in 2019.
  • Business Quant data shows Intangibles for APVO at $4.4 million in Q4 2019, $4.6 million in Q3 2019, and $4.8 million in Q2 2019.